We are live on
!
Find out more
Pictet Asset Management Portfolio holdings
AUM
$105B
1-Year Est. Return
38.07%
This Fund
S&P 500
This Quarter
Est. Return
-2.69%
1 Year Est. Return
+38.07%
3 Year Est. Return
+113.98%
5 Year Est. Return
–
10 Year Est. Return
–
AUM
$90B
AUM Growth
-$2.64B
(-2.9%)
Cap. Flow
+$2.07B
Cap. Flow
% of AUM
2.3%
Top 10 Holdings %
Top 10 Hldgs %
17.41%
Holding
2,101
New
60
Increased
1,058
Reduced
623
Closed
92
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Synopsys
SNPS
|
+$327M |
| 2 |
Broadcom
AVGO
|
+$315M |
| 3 |
Mastercard
MA
|
+$262M |
| 4 |
Intuit
INTU
|
+$226M |
| 5 |
Digital Realty Trust
DLR
|
+$149M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
ITCI
Intra-Cellular Therapies Inc.
ITCI
|
+$187M |
| 2 |
Alphabet (Google) Class A
GOOGL
|
+$169M |
| 3 |
WCN
Waste Connections
WCN
|
+$141M |
| 4 |
NextEra Energy
NEE
|
+$134M |
| 5 |
Cadence Design Systems
CDNS
|
+$127M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 31.36% |
| 2 | Industrials | 16.63% |
| 3 | Healthcare | 13.3% |
| 4 | Financials | 8.12% |
| 5 | Consumer Discretionary | 7.67% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
|
K
576
DELISTED
Kellanova
K
| $13.9M | 0.02% |
168,570
+3,913
| +2% | +$321K |
|
577
Rhythm Pharmaceuticals
RYTM
$8.1B
| $13.9M | 0.02% |
259,346
-116,003
| -31% | -$6.44M |
|
578
Coca-Cola Europacific Partners
CCEP
$47.3B
| $13.8M | 0.02% |
159,060
+5,800
| +4% | +$473K |
|
579
Stellantis
STLA
$20.2B
| $13.7M | 0.02% |
1,240,132
+29,454
| +2% | +$379K |
|
|
FOLD
580
DELISTED
Amicus Therapeutics
FOLD
| $13.7M | 0.02% |
1,628,213
+110,577
| +7% | +$1.02M |
|
581
Alkermes
ALKS
$8.44B
| $13.7M | 0.02% |
411,321
-408,660
| -50% | -$13.3M |
|
582
Halliburton
HAL
$27.7B
| $13.5M | 0.02% |
533,740
-18,997
| -3% | -$499K |
|
583
Ingevity
NGVT
$2.62B
| $13.5M | 0.02% |
340,161
+54,463
| +19% | +$2.41M |
|
584
iShares Gold Trust
IAU
$65.4B
| $13.5M | 0.01% |
231,500
-119,000
| -34% | -$6.44M |
|
585
Regions Financial
RF
$26.9B
| $13.5M | 0.01% |
619,092
+38,016
| +7% | +$886K |
|
|
IPG
586
DELISTED
Interpublic Group of Companies
IPG
| $13.4M | 0.01% |
493,599
-129,618
| -21% | -$3.56M |
|
587
M&T Bank
MTB
$36.6B
| $13.3M | 0.01% |
74,570
+1,498
| +2% | +$284K |
|
588
Southern Copper
SCCO
$165B
| $13.3M | 0.01% |
151,118
-428
| -0.3% | -$38K |
|
589
Zimmer Biomet
ZBH
$18.7B
| $13.3M | 0.01% |
117,096
-3,519
| -3% | -$376K |
|
590
Huntington Bancshares
HBAN
$36.1B
| $13.2M | 0.01% |
882,136
+31,997
| +4% | +$515K |
|
591
Flutter Entertainment
FLUT
$17B
| $13.2M | 0.01% |
59,449
+2,128
| +4% | +$551K |
|
592
Rollins
ROL
$17.6B
| $13.1M | 0.01% |
243,228
-4,171
| -2% | -$209K |
|
593
Vulcan Materials
VMC
$36.3B
| $13.1M | 0.01% |
56,046
-2,309
| -4% | -$586K |
|
594
Travere Therapeutics
TVTX
$5.86B
| $13.1M | 0.01% |
665,570
-43,820
| -6% | -$889K |
|
595
Reliance Steel & Aluminium
RS
$21.8B
| $12.9M | 0.01% |
44,647
-9,220
| -17% | -$2.64M |
|
596
Coinbase
COIN
$39.3B
| $12.8M | 0.01% |
74,413
+3,497
| +5% | +$847K |
|
597
General Dynamics
GD
$107B
| $12.8M | 0.01% |
46,805
-2,185
| -4% | -$568K |
|
|
AKRO
598
DELISTED
Akero Therapeutics
AKRO
| $12.7M | 0.01% |
+314,711
| New | +$13.3M |
|
599
Hewlett Packard
HPE
$77.8B
| $12.6M | 0.01% |
819,579
+25,759
| +3% | +$513K |
|
600
Trade Desk
TTD
$6.34B
| $12.6M | 0.01% |
230,775
+9,148
| +4% | +$828K |
|
Similar funds
Pictet Asset Management's Q1 2025 Portfolio in Review
As of Q1 2025, Pictet Asset Management held 2,101 positions worth $90B, down 2.9% from $92.7B the previous quarter. Its ten largest holdings account for 17% of the portfolio.
Pictet Asset Management's Q1 2025 filing shows 60 new, 1,058 increased, 623 reduced and 92 closed positions. Its largest new stake was Verona Pharma: 703,063 shares worth $44.6M. The largest sale was Intra-Cellular Therapies Inc., an estimated $187M.
By sector, the portfolio is most concentrated in Technology at 31% of assets, down from 32% a quarter earlier, followed by Industrials and Healthcare.
- Pictet Asset Management's largest Q1 2025 buy was Verona Pharma: 703,063 shares worth $44.6M.
- Pictet Asset Management added most to Synopsys in Q1 2025, an estimated $327M increase.
- Pictet Asset Management's biggest Q1 2025 reduction was Intra-Cellular Therapies Inc., cutting an estimated $187M.
- Pictet Asset Management fully exited iShares iBoxx $ High Yield Corporate Bond ETF in Q1 2025, selling an estimated $46.5M.
- Pictet Asset Management's ten largest holdings make up 17% of its $90B portfolio in Q1 2025.
- Pictet Asset Management opened 60 new positions and closed 92 in Q1 2025.
- Pictet Asset Management's portfolio value fell 2.9% quarter-over-quarter to $90B.
Based on Pictet Asset Management's 13F filing for Q1 2025, filed 5 May 2025.